JPRN-UMIN000019230已完成2 期
A phase II study of weekly paclitaxel in patients with advanced or recurrent esophageal cancer who had previously received docetaxel-containing chemotherapy - A phase II study of weekly paclitaxel in patients with advanced or recurrent esophageal cancer who had previously received docetaxel-containing chemotherapy
niversity of Miyazaki Hospital0 个研究点目标入组 25 人开始时间: 2015年10月13日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Pregnant or lactating women 2)Symptomatic brain metastasis 3)Synchronous or metachronous (within 5 years) malignancies except for mucosal tumors of gastrointestinal tract 4)Severe complications (serious cerebrovascular disorders, uncontrollable hypertension, uncontrollable diabetes mellitus, active ulceration) 5)Active bacterial or fungous infection 6)Interstitial pneumonitis or pulmonary fibrosis 7)Massive pleural effusion or massive ascites 8)Past histrory of myocardial infarction and angina attack within 6 months 9)Past histrory of congested heart failure 10)Arhythmia requiring treatment 11)Peripheral neuropathy grade >=2 by CTCAE v4.0 12)With a history of allergic reaction to polyoxyethylene castor oil or hydrogenated castor oil 13)Serious psychiatric disease 14)Systemic steroids medication
研究者
相似试验
已完成
2 期
Phase II study of weekly paclitaxel (wP) followed by doxorubicin plus paclitaxel (AP) as neo-adjuvant chemotherapy for triple negative Breast Cancer (WePAP)Primary breast cancerJPRN-UMIN000001205Saitama Breast Cancer Clinical Study Group (SBCCSG)63
已完成
2 期
Phase II study of weekly nab-paclitaxel in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy.JPRN-UMIN000013390ational Hospital Organization Asahikawa Medical center40
已完成
2 期
A phase II study of weekly paclitaxel for advanced or recurrent esophageal canceradvanced or reccurent esophageal cancerJPRN-UMIN000009807Medical Oncology, Hirosaki University Graduate School of Medicine30
未知
2 期
Phase II Trial of Weekly Intravenous Paclitaxel plus Three Weekly Intraperitoneal Carboplatin Administration for Suboptimally Debulked Ovarian and Primary Peritoneal Carcinoma Incorporating Pharmacogenomic Analysis.Ovarian Cancer, Peritoneal CancerJPRN-UMIN000001713Development Organization for Frontier Medical Therapeutics80
进行中（未招募）
1 期
A randomised phase 2 study of paclitaxel with or without GSK1120212 in advanced wt BRAF melanoma - Paclitaxel +/- GSK1120212 in MelanomaEUCTR2011-002545-35-GBniversity of Oxford111